CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 71 filers reported holding CHEMOCENTRYX INC in Q2 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $25,000 | -95.1% | 10,000 | -84.2% | 0.00% | -92.1% |
| Q4 2015 | $512,000 | -83.1% | 63,189 | -87.4% | 0.04% | -83.4% |
| Q3 2015 | $3,029,000 | -22.7% | 500,615 | +5.1% | 0.23% | -28.7% |
| Q2 2015 | $3,920,000 | +2869.7% | 476,293 | +2621.7% | 0.32% | +2575.0% |
| Q1 2015 | $132,000 | -96.3% | 17,500 | -93.1% | 0.01% | -98.1% |
| Q2 2013 | $3,607,000 | – | 255,100 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |